ECTE : Summary for ECHO THERAPEUTICS COM USD0.01 - Yahoo Finance

U.S. Markets closed

Echo Therapeutics, Inc. (ECTE)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.17-0.11 (-39.38%)
At close: 3:23 PM EST
People also watch:
BGMDETRMATOSCLSNNNVC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.28
Open0.28
Bid1.44 x 100
Ask1.53 x 1200
Day's Range0.15 - 0.30
52 Week Range0.15 - 2.84
Volume143,126
Avg. Volume18,776
Market Cap2.04M
BetaN/A
PE Ratio (TTM)-0.13
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 months ago

    Echo Therapeutics, Inc. Announces Second Quarter 2016 Financial Results

    ISELIN, N.J., Aug. 12, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced its financial results for the quarter ended June 30, 2016.  Echo's Quarterly Report on Form 10-Q, as filed with the SEC, may be accessed on the SEC's website, www.sec.gov.

  • Echo Therapeutics Delisted from Nasdaq, Shares Plummet
    Zacks5 months ago

    Echo Therapeutics Delisted from Nasdaq, Shares Plummet

    Shares of Echo Therapeutics Inc. (ECTE) plunged 17.3% to close at $1.48 on Jul 11, after the company announced that it has received a delisting notice from the Nasdaq.

  • PR Newswire5 months ago

    Echo Therapeutics Common Stock to Transition from NASDAQ to OTCQB

    ISELIN, N.J., July 8, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that the company has received notice on July 8, 2016 from the Nasdaq Stock Market (Nasdaq) that trading of the Company's common stock will be suspended on Nasdaq at the opening of business on Tuesday, July 12, 2016, and Nasdaq will file a Form 25 Notification of Delisting with the Securities and Exchange Commission. Effective July 12, 2016, Echo expects that its common stock will trade on the OTCQB® Venture Market, operated by OTC Markets Group Inc. under its current trading symbol "ECTE." Echo anticipates that beginning Tuesday, July 12, 2016, investors will be able to view real-time best bid and ask quotes for "ECTE" at www.otcmarkets.com and through most online broker websites.